Welcome back to The Prof G Show. Today we’re diving into Scott Galloway’s take on the runaway cost of prescription drugs in the United States. As Galloway points out, “American patients pay the highest prices in the world for medicines they often can’t afford.” Big Pharma argues that sky-high prices fund research and development, but in reality they spend more on marketing and lobbying than on breakthroughs. Galloway highlights that companies often hike prices year after year—while their R&D budgets remain flat. He reminds us that taxpayers and patients already underwrite basic research, yet drugmakers lock us into monopoly pricing with patent protections and aggressive legal tactics. The result? Life-saving treatments become inaccessible, and U.S. consumers subsidize lower costs for the rest of the world. Scott Galloway’s call is clear: it’s time for transparency, tighter regulation, and real competition so we stop paying through the nose for our health. Thanks for listening.
Link to Article